Human Psychopharmacology

Aims & Scope

Human Psychopharmacology: Clinical and Experimental provides a forum for the evaluation of clinical and experimental research on both new and established psychotropic medicines.

Experimental studies of other centrally active drugs, including herbal products, in clinical, social and psychological contexts, as well as clinical/scientific papers on drugs of abuse and drug dependency will also be considered.

While the primary purpose of the Journal is to publish the results of clinical research, the results of animal studies relevant to human psychopharmacology are welcome.

The following topics are of special interest to the editors and readers of the Journal: -All aspects of clinical psychopharmacology- Efficacy and safety studies of novel and standard psychotropic drugs- Studies of the adverse effects of psychotropic drugs- Effects of psychotropic drugs on normal physiological processes- Geriatric and paediatric psychopharmacology- Ethical and psychosocial aspects of drug use and misuse- Psychopharmacological aspects of sleep and chronobiology- Neuroimaging and psychoactive drugs- Phytopharmacology and psychoactive substances- Drug treatment of neurological disorders- Mechanisms of action of psychotropic drugs- Ethnopsychopharmacology- Pharmacogenetic aspects of mental illness and drug response- Psychometrics: psychopharmacological methods and experimental design

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.7
2024	1.80

SJR (SCImago Journal Rank)

Year	Value
2024	0.510

Quartile

Year	Value
2024	Q3

h-index

Year	Value
2024	87

Journal Rank

Year	Value
2024	11412

Journal Citation Indicator

Year	Value
2024	179

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Neuroscience, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Circadian rhythm disturbances in depression

  Citation: 481

  Authors: Anne, David J.

• Major depressive disorder is accompanied with oxidative stress: short‐term antidepressant treatment does not alter oxidative–antioxidative systems

  Citation: 386

  Authors: Asli, Emre, Salih Saygin, Selda, Ebru, Selcuk

• Cannabis and anxiety: a critical review of the evidence

  Citation: 384

  Authors: José Alexandre, Antonio Waldo, Rocio, Sagnik, Zerrin, Philip, Paolo

• Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders

  Citation: 260

  Authors: Bruce S., Ana Maria

• Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

  Citation: 258

  Authors: A. C.

• Antidepressants and their effect on sleep

  Citation: 245

  Authors: Andrew G., David S.

• Cytokines: abnormalities in major depression and implications for pharmacological treatment

  Citation: 240

  Authors: Sinead M., Lucinda V., Timothy G.

• Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled study

  Citation: 234

  Authors: Fabiano G., Emel S., John P., Manoela, Giovana B., Benício N., Charles L., Jair C.

• The use of ketamine as an antidepressant: a systematic review and meta‐analysis

  Citation: 233

  Authors: Caoimhe M., Keith R.

• Marijuana, alcohol and actual driving performance

  Citation: 225

  Authors: J. G., H. W. J., J. F.

---